SCOPUS 정보 검색 플랫폼

Endocrine Research

Volumn 36, Issue 4, 2011, Pages 142-148

Serum FGF-21 levels in type 2 diabetic patients

(4) Cheng, Xingbo a Zhu, Bei a Jiang, Fusong a Fan, Huaying a

a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY (China)

Author keywords

FGF 21; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; FIBROBLAST GROWTH FACTORS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; WAIST-HIP RATIO;

EID: 80053645063 PISSN: 07435800 EISSN: 15324206 Source Type: Journal
DOI: 10.3109/07435800.2011.558550 Document Type: Article

Times cited : (57)

References (26)

1
- 0031600117
- The heparan sulfate-fibroblast growth factor family: Diversity of structure and function
- Mckeehan WL, Wang F, Kan M. The heparan sulfate-fibroblast growth factor family: Diversity of structure and function. Prog Nucleic Acid Res Mol Bio 1998;59:135-176.
- (1998) Prog Nucleic Acid Res Mol Bio , vol.59 , pp. 135-176
- Mckeehan, W.L.¹ Wang, F.² Kan, M.³

2
- 0031317928
- Fibroblast growth factors and their receptors
- Galzie ZKA, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol 1997;75: 669-685. (Pubitemid 127733222)
- (1997) Biochemistry and Cell Biology , vol.75 , Issue.6 , pp. 669-685
- Galzie, Z.¹ Kinsella, A.R.² Smith, J.A.³

3
- 0033783352
- Fibroblast growth factors, their receptors and signaling
- Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;7:165-197.
- (2000) Endocr Relat Cancer , vol.7 , pp. 165-197
- Powers, C.J.¹ McLeskey, S.W.² Wellstein, A.³

4
- 0033593404
- Morphogenesis
- DOI 10.1016/S0092-8674(00)80562-0
- Hogan BL. Morphogenesis. Cell 1999;96:225-233. (Pubitemid 29059352)
- (1999) Cell , vol.96 , Issue.2 , pp. 225-233
- Hogan, B.L.M.¹

5
- 0035081241
- Fibroblast growth factors
- REVIEWS3005
- Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001;2: REVIEWS3005.
- (2001) Genome Biol , vol.2
- Ornitz, D.M.¹ Itoh, N.²

6
- 2542505481
- Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes
- DOI 10.1210/en.2003-1671
- Fu L, John LM, Adams SH, et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin deficient diabetes. Endocrinology 2004;145:2594-2603. (Pubitemid 38686202)
- (2004) Endocrinology , vol.145 , Issue.6 , pp. 2594-2603
- Fu, L.¹ John, L.M.² Adams, S.H.³ Yu, X.X.⁴ Tomlinson, E.⁵ Renz, M.⁶ Williams, P.M.⁷ Soriano, R.⁸ Corpuz, R.⁹ Moffat, B.¹⁰ Vandlen, R.¹¹ Simmons, L.¹² Foster, J.¹³ Stephan, J.-P.¹⁴ Tsai, S.P.¹⁵ Stewart, T.A.¹⁶

7
- 4744372082
- Evolution of the Fgf and Fgfr gene families
- DOI 10.1016/j.tig.2004.08.007, PII S0168952504002410
- Itoh N, Ornitz DM. Evolution of the FGF and FGFR gene families. Trends Genet 2004;20:563-569. (Pubitemid 39314564)
- (2004) Trends in Genetics , vol.20 , Issue.11 , pp. 563-569
- Itoh, N.¹ Ornitz, D.M.²

8
- 20444435873
- FGF-21 as a novel metabolic regulator
- DOI 10.1172/JCI23606
- Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005;115:1627-1635. (Pubitemid 40814671)
- (2005) Journal of Clinical Investigation , vol.115 , Issue.6 , pp. 1627-1635
- Kharitonenkov, A.¹ Shiyanova, T.L.² Koester, A.³ Ford, A.M.⁴ Micanovic, R.⁵ Galbreath, E.J.⁶ Sandusky, G.E.⁷ Hammond, L.J.⁸ Moyers, J.S.⁹ Owens, R.A.¹⁰ Gromada, J.¹¹ Brozinick, J.T.¹² Hawkins, E.D.¹³ Wroblewski, V.J.¹⁴ Li, D.-S.¹⁵ Mehrbod, F.¹⁶ Jaskunas, S.R.¹⁷ Shanafelt, A.B.¹⁸

9
- 33846418834
- The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
- DOI 10.1210/en.2006-1168
- Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007;148:774-781. (Pubitemid 46143178)
- (2007) Endocrinology , vol.148 , Issue.2 , pp. 774-781
- Kharitonenkov, A.¹ Wroblewski, V.J.² Koester, A.³ Chen, Y.-F.⁴ Clutinger, C.K.⁵ Tigno, X.T.⁶ Hansen, B.C.⁷ Shanafelt, A.B.⁸ Etgen, G.J.⁹

10
- 0036086285
- A mouse model of hepatocellular carcinoma: Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
- Nicholes K, Guillet S, Tomlison E, et al. A mouse model of hepatocellular carcinoma. Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol 2002;160:2295-2307. (Pubitemid 34663420)
- (2002) American Journal of Pathology , vol.160 , Issue.6 , pp. 2295-2307
- Nicholes, K.¹ Guillet, S.² Tomlinson, E.³ Hillan, K.⁴ Wright, B.⁵ Frantz, G.D.⁶ Pham, T.A.⁷ Dillard-Telm, L.⁸ Tsai, S.P.⁹ Stephan, J.-P.¹⁰ Stinson, J.¹¹ Stewart, T.¹² French, D.M.¹³

11
- 0034697846
- Identification of a novel FGF, FGF-21, preferentially expressed in the liver
- DOI 10.1016/S0167-4781(00)00067-1, PII S0167478100000671
- Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 2000;1492:203-206. (Pubitemid 30349198)
- (2000) Biochimica et Biophysica Acta - Gene Structure and Expression , vol.1492 , Issue.1 , pp. 203-206
- Nishimura, T.¹ Nakatake, Y.² Konishi, M.³ Itoh, N.⁴

12
- 33750587755
- Fibroblast growth factor-21 improves pancreatic β-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways
- DOI 10.2337/db05-1435
- Wente W, Efanov AM, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic ǎ-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 2006;55:2470-2478. (Pubitemid 44871147)
- (2006) Diabetes , vol.55 , Issue.9 , pp. 2470-2478
- Wente, W.¹ Efanov, A.M.² Brenner, M.³ Kharitonenkov, A.⁴ Koster, A.⁵ Sandusky, G.E.⁶ Sewing, S.⁷ Treinies, I.⁸ Zitzer, H.⁹ Gromada, J.¹⁰

13
- 34447265235
- PPARα is a key regulator of hepatic FGF21
- DOI 10.1016/j.bbrc.2007.06.068, PII S0006291X07013083
- Lundasen T, Hunt MC, Nilsson LM, et al. PPARá is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 2007;360:437-440. (Pubitemid 47039157)
- (2007) Biochemical and Biophysical Research Communications , vol.360 , Issue.2 , pp. 437-440
- Lundasen, T.¹ Hunt, M.C.² Nilsson, L.-M.³ Sanyal, S.⁴ Angelin, B.⁵ Alexson, S.E.H.⁶ Rudling, M.⁷

14
- 34249686631
- Endocrine regulation of the fasting response by PPARá-mediated induction of fibroblast growth factor 21
- DOI 10.1016/j.cmet.2007.05.003, PII S1550413107001301
- Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARá- mediated induction of fibroblast growth factor 21. Cell Metab 2007;5:415-425. (Pubitemid 46825496)
- (2007) Cell Metabolism , vol.5 , Issue.6 , pp. 415-425
- Inagaki, T.¹ Dutchak, P.² Zhao, G.³ Ding, X.⁴ Gautron, L.⁵ Parameswara, V.⁶ Li, Y.⁷ Goetz, R.⁸ Mohammadi, M.⁹ Esser, V.¹⁰ Elmquist, J.K.¹¹ Gerard, R.D.¹² Burgess, S.C.¹³ Hammer, R.E.¹⁴ Mangelsdorf, D.J.¹⁵ Kliewer, S.A.¹⁶

15
- 33845407972
- Molecular determinants of FGF-21 activity - Synergy and cross-talk with PPARγ signaling
- DOI 10.1002/jcp.20847
- Moyers JS, Shiyanova TL, Mehrbod F, et al. Molecular determinants of FGF-21 activity-synergy and cross-talk With PPARã Signaling. J Cell Physiol 2007;210:1-6. (Pubitemid 44904695)
- (2007) Journal of Cellular Physiology , vol.210 , Issue.1 , pp. 1-6
- Moyers, J.S.¹ Shiyanova, T.L.² Mehrbod, F.³ Dunbar, J.D.⁴ Noblitt, T.W.⁵ Otto, K.A.⁶ Reifel-Miller, A.⁷ Kharitonenkov, A.⁸

16
- 48349146527
- Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
- Zhang X, Yeung DC, Karpisek M, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008;57:1246-1253.
- (2008) Diabetes , vol.57 , pp. 1246-1253
- Zhang, X.¹ Yeung, D.C.² Karpisek, M.³

17
- 0031851293
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
- DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553. (Pubitemid 28319935)
- (1998) Diabetic Medicine , vol.15 , Issue.7 , pp. 539-553
- Alberti, K.G.M.M.¹ Zimmet, P.Z.²

18
- 0021813187
- Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
- DOI 10.1007/BF00280883
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and ǎ-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
- (1985) Diabetologia , vol.28 , Issue.7 , pp. 412-419
- Matthews, D.R.¹ Hosker, J.P.² Rudenski, A.S.³

19
- 18144423534
- Structural basis for fibroblast growth factor receptor activation
- DOI 10.1016/j.cytogfr.2005.01.008
- Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 2005;16:107-137. (Pubitemid 40616111)
- (2005) Cytokine and Growth Factor Reviews , vol.16 , Issue.2 SPEC. ISS. , pp. 107-137
- Mohammadi, M.¹ Olsen, S.K.² Ibrahimi, O.A.³

20
- 34249697012
- βKlotho is required for metabolic activity of fibroblast growth factor 21
- DOI 10.1073/pnas.0701600104
- Ogawa Y, Kurosu H, Yamamoto M, et al. ǎ-Klotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci USA 2007;104:7432-7437. (Pubitemid 47185923)
- (2007) Proceedings of the National Academy of Sciences of the United States of America , vol.104 , Issue.18 , pp. 7432-7437
- Ogawa, Y.¹ Kurosu, H.² Yamamoto, M.³ Nandi, A.⁴ Rosenblatt, K.P.⁵ Goetz, R.⁶ Eliseenkova, A.V.⁷ Mohammadi, M.⁸ Kuro-O, M.⁹

21
- 54549120193
- Plasma FGF-21 levels in type 2 diabetic patients with ketosis
- Li L, Yang GY, Ning H, Yang ML, Liu H, Chen WW. Plasma FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract 2008;82:209-213.
- (2008) Diabetes Res Clin Pract , vol.82 , pp. 209-213
- Li, L.¹ Yang, G.Y.² Ning, H.³ Yang, M.L.⁴ Liu, H.⁵ Chen, W.W.⁶

22
- 39449127028
- Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus
- DOI 10.1055/s-2007-985148
- Chen WW, Li L, Yang GY, et al. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2008;116:65-68. (Pubitemid 351270911)
- (2008) Experimental and Clinical Endocrinology and Diabetes , vol.116 , Issue.1 , pp. 65-68
- Chen, W.-W.¹ Li, L.² Yang, G.-Y.³ Li, K.⁴ Qi, X.-Y.⁵ Zhu, W.⁶ Tang, Y.⁷ Liu, H.⁸ Boden, G.⁹

23
- 33745197808
- The role of leptin in leptin resistance and obesity
- Zhang Y, Scarpace PJ. The role of leptin in leptin resistance and obesity. Physiol Beav 2006;88:249-256.
- (2006) Physiol Beav , vol.88 , pp. 249-256
- Zhang, Y.¹ Scarpace, P.J.²

24
- 64549152937
- Serum levels of the adipokine FGF21 depend on renal function
- Stein S, Bachmann A, Lossner U, et al. Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 2009;32:126-128.
- (2009) Diabetes Care , vol.32 , pp. 126-128
- Stein, S.¹ Bachmann, A.² Lossner, U.³

25
- 62149139387
- Different roles of N- and C-termini in the functional activity of FGF21
- Micanovic R, Raches DW, Dunbar JD, et al. Different roles of N- and C-termini in the functional activity of FGF21. J Cell Physiol 2008;219:227-234.
- (2008) J Cell Physiol , vol.219 , pp. 227-234
- Micanovic, R.¹ Raches, D.W.² Dunbar, J.D.³

26
- 57849155278
- FGF21 N- and C-termini play different roles in receptor interaction and activation
- Yie J, Hecht R, Patel J, et al. FGF21 N- and C-termini play different roles in receptor interaction and activation. FEBS Lett 2009;583:19-24.
- (2009) FEBS Lett , vol.583 , pp. 19-24
- Yie, J.¹ Hecht, R.² Patel, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.